Compare Cigna Corp (CI) vs General Mills, Inc. (GIS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs General Mills, Inc. — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while General Mills, Inc. trades at $37.93 (market cap $19.89B). The key difference: Cigna Corp is far larger — about 3.7× General Mills, Inc.'s market cap, and General Mills, Inc. pays the higher dividend (6.55%). Which is the better fit depends on your goals.
| CI | GIS | |
|---|---|---|
Market Cap | $73.56B | $19.89B |
Sector | Health | Consumer Staples |
52-Week High | $311.00 | $51.11 |
52-Week Low | $244.41 | $32.17 |
Enterprise Value | $98.27B | $33.37B |
Dividend Yield | 2.24% | 6.55% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
General Mills (GIS) trades at $36.89, up 2.27% today, with a bullish technical signal from moving averages. The stock shows mixed fundamentals with declining revenue ($19.49B in 2025) and negative net income margin (-0.48%), though it beat Q2 2026 EPS estimates. Valuation appears attractive with P/E of 9.23 and P/S of 1.08. Recent news highlights cost-saving initiatives and new product launches, while analyst consensus remains cautious with 61% hold ratings.
Outlook: GIS faces headwinds from soft consumer demand and margin pressure, but its cost-saving strategy and dividend yield offer some stability. Risks include competitive threats and high debt levels. The stock presents a value opportunity for income-focused investors if management can execute its turnaround plan effectively.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About General Mills, Inc.
General Mills is a leading global packaged food company that produces snacks, cereal, convenient meals, yogurt, dough, baking mixes and ingredients, pet food, and superpremium ice cream. Its largest brands are Nature Valley, Cheerios, Old El Paso, Yoplait, Pillsbury, Betty Crocker, BLUE, and Haagen-Dazs. In fiscal 2022, 77% of its revenue was derived from the United States, although the company also operates in Canada, Europe, Australia, Asia, and Latin America. While most of General Mills' products are sold through retail stores to consumers, the company also sells products into the food-service channel and the commercial baking industry.
Read more on GIS →
